DHANUKA - Dhanuka Agritech
📢 Recent Corporate Announcements
Dhanuka Agritech has received an assessment order for the Assessment Year 2018-19 from the Assistant Commissioner of Income Tax, New Delhi. The order demands a payment of ₹83.71 lakhs, which includes both tax and interest, due to the disallowance of CSR expenditures claimed under Section 80G. The company has formally challenged this demand by filing a writ petition, maintaining that the claim is not sustainable. Management has stated that this development will not have a significant impact on the company's financial or operational performance.
- Income Tax demand of ₹83.71 lakhs received for Assessment Year 2018-19
- Dispute involves disallowance of CSR activities claimed under Section 80G of the Income Tax Act
- Company has already filed a writ petition against the assessment order
- Management expects no material impact on financials or operations
- The demand amount includes both the base tax and accrued interest
Dhanuka Agritech Limited has initiated a postal ballot process to seek shareholder approval for the appointment of Mr. Sanjiv Goel as an Independent Director. The proposed appointment is for a first term of five years, effective from February 5, 2026, to February 4, 2031. Shareholders can cast their votes electronically through the NSDL platform between February 18 and March 19, 2026. This move is part of the company's compliance with SEBI and Companies Act regulations regarding board composition.
- Proposed appointment of Mr. Sanjiv Goel as an Independent Director for a 5-year tenure.
- The appointment term is scheduled from February 5, 2026, to February 4, 2031.
- Remote e-voting period commences on February 18, 2026, and ends on March 19, 2026.
- The cut-off date for determining shareholder eligibility for voting was February 13, 2026.
- Final results of the postal ballot will be announced on or before March 23, 2026.
Dhanuka Agritech reported a challenging Q3 FY26 with revenue declining 7.9% YoY to ₹409.92 crores and PAT falling 27.3% to ₹40 crores. The performance was hampered by weak demand in South and West India, lower crop prices, and regulatory hurdles in the biologicals segment which caused a ₹49 crore impact over nine months. However, management expressed optimism for Q4, citing a strong start in January and the commercialization of new products from the Dahej plant. The company maintains a healthy cash position of over ₹250 crores and expects biostimulant approvals by the end of the current quarter.
- Revenue from operations decreased to ₹409.92 crores in Q3 FY26 from ₹445.27 crores in Q3 FY25
- EBITDA fell significantly to ₹58.66 crores compared to ₹75.56 crores in the previous year's quarter
- Regulatory changes in biostimulants led to a significant sales impact of ₹49 crores during the first nine months of FY26
- Management targets EBITDA-positive operations for the Dahej plant in FY27 with 80% capacity utilization
- Cash and liquid investments remain strong at over ₹250 crores as of December 2025
Dhanuka Agritech Limited has received three demand orders from the Excise & Taxation Department, Gurugram, totaling ₹14.96 crore. These demands relate to alleged unpaid entry tax liabilities for the financial years 2015-16, 2016-17, and 2017-18. The company has stated that these demands are not maintainable and is exploring legal remedies, including filing a writ petition. Management does not expect any significant impact on the company's financial or operational performance at this stage.
- Total tax demand of ₹14.96 crore issued by the Excise & Taxation Department, Gurugram.
- The demand includes ₹11.95 crore for FY 2015-16, ₹0.06 crore for FY 2016-17, and ₹2.95 crore for FY 2017-18.
- Allegations involve failure to discharge entry tax under the Haryana Tax on Entry of Goods into Local Areas Act, 2008.
- Company is evaluating legal options and believes the demands are not legally maintainable.
- Management anticipates no material impact on current operations or financial stability.
Dhanuka Agritech has released the audio recording of its analyst and institutional investor meet held on February 5, 2026. The call discussed the company's unaudited financial results for the third quarter and nine months ended December 31, 2025. This disclosure is a standard regulatory requirement under SEBI (LODR) Regulations to ensure transparency for all shareholders. Investors can access the management's commentary on business performance and future outlook via the provided digital link.
- Audio recording of the Q3 and 9M FY26 earnings call is now publicly available via the company's website.
- The investor call was conducted on February 5, 2026, following the board's approval of financial results.
- The disclosure complies with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- The recording provides management insights into the company's performance for the period ending December 31, 2025.
Dhanuka Agritech reported a weak set of numbers for Q3 FY26, with revenue from operations declining 7.94% YoY to ₹409.92 Crores. Profitability took a significant hit as PAT fell 27.33% to ₹40 Crores, and EBITDA margins contracted by 266 bps to 14.31%. The company attributed the decline to stressed demand drivers, including adverse weather and low crop prices, particularly in South and West India. Management has issued a cautious guidance for the full year FY26, expecting flat revenue and a 100 bps decline in EBITDA margins.
- Revenue from operations decreased 7.94% YoY to ₹409.92 Crores in Q3 FY26.
- EBITDA declined by 22.37% YoY to ₹58.66 Crores, with margins contracting to 14.31%.
- Net Profit (PAT) dropped 27.33% YoY to ₹40.00 Crores from ₹55.04 Crores in Q3 FY25.
- Management expects flat revenue for FY26 and a margin compression of approximately 100 bps.
- Innovation Turnover Index (new molecules) contributed 16.32% to total revenue for 9M FY26.
Dhanuka Agritech reported a weak performance for the quarter ended December 31, 2025, with revenue from operations falling 7.9% YoY to ₹409.91 crore. Net profit witnessed a sharper decline of 27.3% YoY, dropping to ₹39.99 crore from ₹55.04 crore in the previous year's corresponding quarter. The company's profitability was impacted by higher material costs and a ₹2.5 crore provision related to the new Government Labour Codes. Additionally, the board announced the appointment of Mr. Sanjiv Goel as an Independent Director following the completion of Mr. Sachin Kumar Bhartiya's tenure.
- Revenue from operations decreased 7.9% YoY to ₹409.91 crore in Q3 FY26.
- Net Profit (PAT) declined by 27.3% YoY to ₹39.99 crore from ₹55.04 crore.
- Profit Before Tax (PBT) fell to ₹49.73 crore, down from ₹68.08 crore in Q3 FY25.
- Nine-month (9M FY26) PAT stands at ₹189.46 crore compared to ₹221.46 crore in 9M FY25.
- Recognized an incremental impact of ₹2.50 crore in employee benefits due to the new Code on Wages.
Dhanuka Agritech reported a weak set of numbers for Q3 FY26, with revenue from operations declining 7.9% YoY to ₹409.92 crore. Net profit saw a significant contraction of 27.3% YoY, falling to ₹40 crore from ₹55 crore in the same period last year. The company also recognized a ₹2.5 crore impact on employee benefits due to the new Labour Code provisions. Alongside results, the board announced the appointment of Mr. Sanjiv Goel as an Independent Director for five years, replacing Mr. Sachin Kumar Bhartiya.
- Revenue from operations fell to ₹40,991.67 lacs in Q3 FY26 compared to ₹44,527.21 lacs in Q3 FY25.
- Net Profit for the quarter declined 27.3% YoY to ₹3,999.54 lacs.
- Nine-month (9M) PAT decreased to ₹18,946.43 lacs from ₹22,145.80 lacs in the previous year.
- Recognized an incremental impact of ₹250 lakhs in employee expenses due to the Code on Wages, 2019.
- Mr. Sanjiv Goel appointed as Independent Director for a 5-year term effective February 5, 2026.
Dhanuka Agritech reported a weak set of numbers for Q3 FY26, with revenue from operations declining 7.9% year-on-year to ₹409.92 crore. Net profit for the quarter fell significantly by 27.3% to ₹40 crore, down from ₹55.04 crore in the same period last year. The company attributed performance variations to seasonal factors like monsoon and pest infestation patterns. Additionally, the board has appointed Mr. Sanjiv Goel as an Independent Director for a five-year term starting February 2026, following the cessation of Mr. Sachin Kumar Bhartiya's term.
- Revenue from operations decreased to ₹409.92 crore in Q3 FY26 compared to ₹445.27 crore in Q3 FY25.
- Net profit for the quarter declined 27.3% YoY to ₹40 crore, with EPS dropping to ₹8.87 from ₹12.25.
- Nine-month PAT for FY26 stands at ₹189.46 crore, a 14.4% decrease from ₹221.46 crore in the previous year.
- Recognized a ₹2.5 crore incremental impact in employee benefits due to the new Code on Wages compliance.
- Mr. Sanjiv Goel appointed as Independent Director for 5 years; Mr. Sachin Kumar Bhartiya to exit on Feb 8, 2026.
Dhanuka Agritech reported a weak performance for the quarter ended December 31, 2025, with revenue from operations falling 7.9% YoY to ₹409.92 crore. Net profit saw a sharper decline of 27.3% YoY, landing at ₹40 crore compared to ₹55.04 crore in the previous year's quarter. The nine-month profit for FY26 also showed a downward trend, decreasing by 14.4% to ₹189.46 crore. Alongside financial results, the company announced the appointment of Mr. Sanjiv Goel as an Independent Director and the cessation of Mr. Sachin Kumar Bhartiya's term.
- Revenue from operations decreased 7.9% YoY to ₹409.92 crore in Q3 FY26.
- Net profit for the quarter fell 27.3% YoY to ₹40 crore from ₹55.04 crore.
- Nine-month revenue stands at ₹1,536.45 crore, down 3.5% from ₹1,593.13 crore in the previous year.
- Earnings Per Share (EPS) for the quarter dropped to ₹8.87 from ₹12.25 YoY.
- Recognized a ₹2.5 crore incremental impact on employee benefits due to the notification of new Labour Codes.
Dhanuka Agritech Limited has filed its quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. The filing confirms that for the quarter ended December 31, 2025, all dematerialization requests were processed timely. The company's RTA, Abhipra Capital Limited, verified that physical share certificates were cancelled and the register of members was updated within 15 days. This is a standard procedural disclosure required for all listed entities in India.
- Compliance certificate issued for the quarter ended December 31, 2025
- RTA Abhipra Capital Limited confirmed processing of demat requests
- Physical certificates were mutilated and cancelled as per SEBI guidelines
- Register of members updated with depository names within 15 days
Dhanuka Agritech Limited has announced the closure of its trading window starting January 1, 2026, in compliance with SEBI insider trading regulations. This closure is ahead of the declaration of the un-audited financial results for the quarter and nine months ending December 31, 2025. The window will remain closed until 48 hours after the results are officially announced to the exchanges. The specific date for the board meeting to approve these results will be communicated at a later date.
- Trading window closure starts on January 1, 2026.
- Closure pertains to the financial results for the quarter and nine months ending December 31, 2025.
- Trading restriction ends 48 hours after the financial results are declared.
- Applies to all designated persons and those in possession of unpublished price sensitive information.
Dhanuka Agritech has been served a demand order totaling Rs 1.64 crores by the State Goods & Services Department of Rajasthan. The demand includes a tax component of Rs 92.79 Lakhs, interest of Rs 62.63 Lakhs, and a penalty of Rs 9.27 Lakhs. The allegations pertain to non-payment of GST on certain Directors' Remuneration and short payment on miscellaneous receipts. The company believes the demand is not maintainable and is preparing to file an appeal, expecting no significant impact on its financials.
- Total demand order of Rs 1.64 crores received from Rajasthan State GST authorities.
- Breakdown includes Rs 92.79 Lakhs in tax, Rs 62.63 Lakhs in interest, and Rs 9.27 Lakhs in penalty.
- Allegations involve GST non-payment on Directors' Remuneration and miscellaneous receipts.
- Company is evaluating legal options and intends to file an appeal against the order.
- Management states there is no expected material impact on operations or financials.
Dhanuka Agritech Limited announced the appointment of Mr. Mahesh Parshuram Sonawane as Senior Management Personnel, specifically as General Manager- Quality, effective December 15th, 2025. Mr. Sonawane brings over 22 years of experience in Quality Management. He previously held senior leadership positions at Atul Limited, Syngenta India Limited, and Bayer CropScience Ltd. This appointment strengthens the company's quality assurance capabilities.
- Mr. Mahesh Parshuram Sonawane appointed as General Manager- Quality w.e.f. 15th December 2025
- Mr. Sonawane has over 22 years of experience in Quality Management
- Mr. Sonawane holds a Master of Science (M.Sc.) degree in Chemistry
- Mr. Sonawane previously worked at Atul Limited, Syngenta India Limited, and Bayer CropScience Ltd.
Dhanuka Agritech reported a weak set of numbers for the quarter ended September 30, 2025. Revenue from operations decreased by 8.5% YoY to ₹598.25 crore, while Net Profit saw a significant drop of 20% to ₹93.97 crore compared to the same period last year. For the first half of FY26, the company's net profit stood at ₹149.47 crore, down from ₹166.41 crore in H1 FY25. The management attributed performance variations to seasonal factors like monsoon and pest infestation patterns.
- Revenue from operations fell 8.5% YoY to ₹598.25 crore in Q2 FY26.
- Net Profit for the quarter declined 20% YoY to ₹93.97 crore from ₹117.52 crore.
- Earnings Per Share (EPS) dropped to ₹20.85 in Q2 FY26 from ₹25.83 in Q2 FY25.
- H1 FY26 total income stood at ₹1,140.90 crore, a slight decrease from ₹1,165.79 crore in H1 FY25.
- Inventory levels increased significantly to ₹478.21 crore as of Sept 30, 2025, compared to ₹398.74 crore in March 2025.
Financial Performance
Revenue Growth by Segment
Consolidated revenue for H1 FY26 grew 2.1% YoY to INR 768.38 Cr compared to INR 752.56 Cr in H1 FY25. For Q2 FY26, consolidated revenue was INR 384.34 Cr, a slight decline of 2.58% from INR 394.55 Cr in Q2 FY25. The Dahej B2B segment contributed approximately INR 22 Cr in revenue during the quarter.
Geographic Revenue Split
Revenue is well-distributed across India, with meaningful contributions from the South, West, North, and East regions. This balanced presence provides stability against regional demand weaknesses caused by localized climatic variations.
Profitability Margins
The Net Profit Margin for the quarter ended September 30, 2025, stood at 13.31%. Historically, the company has maintained healthy PBILDT margins between 15-19% annually. Consolidated Net Profit for Q2 FY26 was INR 66.95 Cr, down 9.9% from INR 74.34 Cr in Q2 FY25.
EBITDA Margin
The PBILDT margin was 18.63% in FY24. Management expects a near-term impact of approximately 100 basis points on EBITDA margins due to the integration of Bayer molecules and current market challenges. The company aims to achieve positive EBITDA for the Dahej facility by FY27.
Capital Expenditure
The company has invested significantly in a technical manufacturing facility at Dahej, Gujarat, for backward integration. While specific current capex figures for FY26 are not detailed, the facility is a key driver for future revenue growth and margin expansion through the production of active ingredients.
Credit Rating & Borrowing
The company maintains a 'Stable' outlook with a strong financial risk profile. It has an exceptionally high interest coverage ratio of 81.50x (FY25) and a low overall gearing of 0.06x as of March 31, 2025. Total debt to Gross Cash Accrual (TD/GCA) stood at 0.21x in FY25.
Operational Drivers
Raw Materials
The company utilizes technical grade chemicals and active ingredients for its formulations. Specific raw materials include active ingredients for herbicides, fungicides, and insecticides. Imports account for 25% to 35% of total raw material requirements.
Import Sources
Raw materials are imported from international markets including the USA, Japan, and China. Domestic sourcing is also utilized to support its formulation business.
Key Suppliers
Dhanuka maintains strategic technical tie-ups with major MNCs, most notably Nissan Chemicals, which contributes approximately 40-45% of the company's revenue. It also recently acquired brands from Bayer Crop Science.
Capacity Expansion
The Dahej plant in Gujarat represents a major shift toward technical manufacturing and backward integration. The company is currently ramping up this facility to manufacture its second active ingredient, aiming for revenue scalability in FY26 and EBITDA breakeven by FY27.
Raw Material Costs
Raw material costs are susceptible to global price volatility and currency fluctuations. The company lacks a formal hedging policy for its 25-35% import component, exposing it to foreign exchange risks.
Manufacturing Efficiency
Efficiency is currently impacted by the underutilization of the newly commissioned Dahej plant. Improving capacity utilization at this facility is a key monitorable for supporting operating leverage and reaching profitability targets.
Logistics & Distribution
Distribution costs are a function of its wide reach across four regional hubs and multiple warehouses serving a vast network of retail points.
Strategic Growth
Expected Growth Rate
7%
Growth Strategy
Growth will be driven by backward integration at the Dahej plant, increasing the contribution of new 9(3) molecules (which were 13.29% of revenue in FY24), and the acquisition of global rights for brands like Melody Duo and Triadimenol from Bayer. The company is also expanding its B2B and export foothold.
Products & Services
The company sells crop protection products including Herbicides, Fungicides, Insecticides, and Biostimulants.
Brand Portfolio
Key brands include Melody Duo and Triadimenol (acquired from Bayer), along with various specialty molecules developed in partnership with Nissan Chemicals.
New Products/Services
New molecules contributed 13.29% of revenue in FY24. The company continues to launch powerful products in the herbicide and fungicide segments, alongside new biostimulant products to drive growth.
Market Expansion
Dhanuka is expanding its presence in the B2B domestic market and increasing its export foothold to diversify beyond the domestic B2C formulation business.
Market Share & Ranking
Dhanuka is a leading player in the Indian agrochemical formulation industry with a track record of over three decades.
Strategic Alliances
Strategic alliances exist with Nissan Chemicals (contributing 40-45% of revenue) and other MNCs for developing and marketing specialty 9(3) molecules.
External Factors
Industry Trends
The industry is shifting toward technical manufacturing and backward integration to combat global price volatility. There is an increasing focus on specialty molecules and biostimulants, though the latter faces recent regulatory scrutiny (July 2025 stay).
Competitive Landscape
The industry is highly competitive and regulated, featuring both large MNCs and domestic generic players. Dhanuka differentiates itself through specialty molecules and technical partnerships.
Competitive Moat
The moat is built on long-term technical tie-ups with MNCs like Nissan Chemicals and a massive distribution network. These advantages are sustainable due to the high entry barriers in developing 9(3) molecules and the time required to build a pan-India retail reach.
Macro Economic Sensitivity
The business is highly sensitive to agricultural GDP and monsoon performance, as rural demand dictates the consumption of crop protection chemicals.
Consumer Behavior
Farmer demand is shifting toward higher-quality specialty chemicals that offer better crop yields and protection, supporting Dhanuka's focus on new molecule launches.
Geopolitical Risks
Trade dynamics with China, Japan, and the USA are critical due to import dependencies. Regulatory changes or trade barriers in these regions could impact raw material availability.
Regulatory & Governance
Industry Regulations
The company faces significant regulatory risks, including potential government bans on specific molecules. In July 2025, the government imposed a stay on bio-stimulants, although the impact on Dhanuka was expected to be limited due to the segment's small revenue share.
Environmental Compliance
As a chemical manufacturer, the company must comply with stringent pollution control norms, particularly for its technical manufacturing facility in Dahej.
Taxation Policy Impact
The company is subject to standard corporate tax rates in India; specific fiscal incentives for the Dahej plant were not detailed.
Legal Contingencies
The company is subject to ongoing regulatory monitoring regarding molecule safety and environmental impact, typical for the agrochemical sector.
Risk Analysis
Key Uncertainties
Climatic variations (monsoon) and regulatory changes (molecule bans) are the primary uncertainties. A sharp decline in revenue or operating margins falling to 10-12% would materially impact cash generation.
Geographic Concentration Risk
Revenue is well-balanced across India, reducing the risk of total revenue loss from a single regional weather event.
Third Party Dependencies
There is a high dependency on MNC partners like Nissan Chemicals for technical supplies and product development, representing 40-45% of revenue.
Technology Obsolescence Risk
The shift from generics to specialty molecules and biostimulants represents a technological evolution; Dhanuka is addressing this through its R&D and MNC tie-ups.
Credit & Counterparty Risk
The company manages receivables tightly within its 10,000+ distributor network to ensure high liquidity and low credit risk.